CSF1R and myeloid sarcoma: This notion is consistent with our findings in the NOD-EAE model of progressive MS, in which attenuating CSF1R signaling in microglia and macrophages not only reduces their proliferative capacity, but also diminishes their neurodegenerative pro-inflammatory phenotype.